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Abstract
 
The aim of this study was to characterize the ability of late-pregnant (days 15–22) rat uterine tissue
rings to contract in response to electric field stimulation 
 
in vitro.
 
 For this purpose, maximum rhythmic
contractions were elicited by optimum choice of the period time and the pulse width, the two main pa-
rameters of electric field stimulation. In parallel, the plasma 17
 
b
 
-estradiol and progesterone levels
were determined. It was found that the contractility ratio, i.e. the quotient of the optimum pulse width
and the period time, is a good parameter with which to express the contractility. The larger the contrac-
tility ratio, the better the ability to contract. Evaluation of the area under the curve did not furnish in-
formation relating to the contractility in this method. A very close correlation was observed between
the contractility ratio and the quotient of the 17
 
b
 
-estradiol and progesterone levels on different days,
demonstrating that the 
 
in vitro
 
 ability characterized by the contractility ratio is in keeping with the
physiological regularity. There was also a very close correlation between the contractility ratio and
the quotient of the 
 
a
 
1
 
- and 
 
b
 
-adrenergic receptors, suggesting the main role of the numbers of 
 
a
 
1
 
-
receptor in pregnant uterine contractility. It is believed that this is the first 
 
in vitro
 
 model to give a nu-
merical measure concerning the ontogeny of uterine contractility in late pregnancy. © 2001 Elsevier
Science Inc. All rights reserved.
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Introduction
 
During pregnancy, the uterus undergoes a maturation process resulting in labour pains and
delivery. This complex mechanism is controlled by a heterogeneous regulation, involving
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physiological factors such as oxytocin, the adrenergic system, prostaglandins, connexin and
sex hormones [1–3]. Animal investigations of uterine contractility in late pregnancy are es-
sential in research relating to the suppression of premature labour, but such investigations are
difficult. During pregnancy, 
 
in vivo
 
 study techniques such as the Millar cathether method of
Csapo [4] are not suitable in the most frequently used animal models (rat, guinea pig and rab-
bit). 
 
In vitro
 
 contractility studies are another possibility, and are accepted for electric field
stimulation (EFS). The few such studies performed so far have concentrated on the excitability
of the uterine muscle through the nerves [5–7] or the changes in response to electric stimuli in
the presence of various drugs [8–11]. However, such investigations are not able to character-
ize the ontogeny proceeding in the contractility of the uterus in late pregnancy.
The aim of the present study was to characterize the ability of such uterine tissues to con-
tract in response to EFS in late pregnancy (days 15–22) in the rat. For this purpose, we set out
to describe the contractility by choosing stimulation parameters necessary to elicit rhythmic
contractions. Additionally, we searched for a correlation between the change in contractility
 
in vitro
 
 and the plasma levels of sex hormones, in the interest of a comparison of our results
with physiological principles. Finally, we determined the changes in density of the adrener-
gic receptors in order to clarify their contributions to the contractility response of the late-
pregnant rat uterus.
 
Methods
 
Uterus preparation and EFS
 
Uteri were removed from Sprague-Dawley rats (250–350 g) on day 15, 18, 20 or 22 of
pregnancy. Muscle rings 0.5 cm long were sliced from the uterine horns and mounted verti-
cally between two platinum electrodes in an organ bath containing 10 ml de Jongh solution
(in mM: 137 NaCl, 3 KCl, 1 CaCl
 
2
 
, 1 MgCl
 
2
 
, 12 NaHCO
 
3
 
, 4 NaH
 
2
 
PO
 
4
 
, 6 glucose, pH: 7.4).
The organ bath was maintained at 37 
 
8
 
C and carbogen (95% O
 
2
 
 
 
1
 
 5% CO
 
2
 
) was bubbled
through it. After mounting, the rings were equilibrated for about 1 h before experiments were
undertaken. The initial tension was set to about 1.25 g, which was relaxed to about 0.5 g at
the end of equilibration. Maximum rhythmic contractions were elicited with a digital, pro-
grammable stimulator (ST-02, Experimetria U.K. Ltd.), using different values of pulse width
(PW, the duration of the electric field as a single stimulus) and period time (PER, the time in-
terval between two stimuli) at 40 V for 240 s. The shortest interval time was sought with
which to elicit rhythmic contractions. After identification of this value, the pulse width was
gradually increased as much as possible at the constant time interval to maintain the rhythmic
contractions. The tension of the myometrial rings was measured with a gauge transducer
(SG-02, Experimetria U.K. Ltd.) and recorded with an ISOSYS Data Acquisition System
(Experimetria U.K. Ltd.). Areas under curves (AUCs) and correlations were evaluated and
were analysed statistically with the Prism 2.01 (GraphPad Software, USA) computer program.
For statistical evaluations, data were analysed by ANOVA Neuman-Keuls post-hoc test.
 
Determination of plasma 17
 
b
 
-estradiol and progesterone
 
Blood samples were collected by cardiac puncture immediately before removal of the
uteri. After centrifugation, the plasma was separated and stored at 
 
2
 
20 
 
8
 
C until determina-
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tion. 17
 
b
 
-Estradiol and progesterone were determined by radioimmunoassay. Reagent kits
were purchased from the WHO Matched Reagent Programme. The lower limits of the 17
 
b
 
-
estradiol and progesterone determinations were 30 pM and 0.5 nM, respectively. No cross-
reaction was found in either case. The intraassay and interassay coefficients of variation for
17
 
b
 
-estradiol were 7.5% and 14.3%, and those for progesterone were 5.2% and 12.7%, re-
spectively. Statistical analysis was carried out as mentioned above.
 
Radioreceptor binding assays
 
Radioligand binding experiments were carried out on the membrane preparation of preg-
nant rat uterus. The preparation was conducted as described by Maltier and Legrand [12].
The reaction mixture contained 100 
 
m
 
l membrane preparation (
 
z
 
0.5 mg/ml protein), 100 
 
m
 
l
tritiated ligand and 100 
 
m
 
l unlabelled ligand for non-specific binding or 100 
 
m
 
l incubation
buffer (consisting of 0.05 M Tris-HCl, 0.01 M MgCl
 
2
 
 and 2.5% ethanol pH 
 
5
 
 7.42) for total
binding. Incubations were started by addition of the membrane suspension and continued in a
shaking water bath until a steady state was achieved (37 
 
8
 
C, 10 min for 
 
a
 
-adrenoceptors and
30 
 
8
 
C, 30 min for 
 
b
 
-adrenoceptors). At the end of the incubation, the bound radioligand was
separated from the residual free radioligand by rapid filtration on a Brandell cell harvester
through Whatman GF/C filters and washed with 3 
 
3
 
 10 ml of ice-cold buffer (Tris-HCl,
pH
 
5
 
 7.42). The bound radioactivity was determined in a HighSafe scintillation cocktail in a
Wallac 1409 liquid scintillation counter.
Saturation analysis of 
 
a
 
1
 
-adrenoceptors was performed by incubating membranes with
0.1–2.5 nM [
 
3
 
H]prazosine with or without 10 
 
m
 
M unlabelled phentolamine. In the case of
 
b
 
-adrenoceptors, the saturation analysis was performed with 0.25–10 nM [
 
3
 
H]dihydroalpre-
nolol in the presence or absence of 1 
 
m
 
M unlabelled propranolol.
Specific binding was determined by subtracting the non-specific binding from the total
binding. All assays were carried out at least three times in duplicate and values are given as
means 
 
6
 
 SEM. In the investigated tissues, the K
 
d
 
 values are 0.48
 
6
 
0.05 and 1.87
 
6
 
0.27 for
 
3
 
[H]prazosine and 
 
3
 
[H]dihydroalprenolol, respectively. Statistical analysis was carried out as
mentioned above.
 
Results
 
The maximum rhythmic contractions elicited by EFS in uterine rings sliced out on preg-
nancy day 15, 18, 20 or 22 are illustrated in 
 
Figure 1 a-d
 
. There were no significant differ-
ences in the average AUCs relating to the contractions (
 
Figure 1 e
 
).
Different PWs and PERs were used for 
 
in vitro
 
 electric field stimulation to elicit maximum
rhythmic contractions. The contractility ratio PW/PER was significantly greater on day 18
than on day 15; there was a significant change between days 18 and 20, and the ratio was
markedly elevated on day 22 (
 
Table 1, Figure 2
 
).
There were changes in the levels of plasma 17
 
b
 
-estradiol and progesterone between days
15 and 22. There were no significant changes in the ratio of 17
 
b
 
-estradiol and progesterone
(E/P) between days 18 and 20, only a slight decrease was observed on day 20, but there was a
sudden increase on day 22 (
 
Table 2, Figure 3
 
).
The maximum numbers of binding sites (B
 
max
 
) for the 
 
a
 
1
 
-receptors and 
 
b
 
-receptors also
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Fig. 1. Representative maximum rhythmic contraction curves elicited by electric field stimulation on day 15 (a),
18 (b), 20 (c) or 22 (d) of pregnancy in vitro, and average areas under the curves of maximum rhythmic contrac-
tions (e) on days 15–22 of pregnancy (ns5not significant).
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changed during the examined period. The ratio of 
 
a
 
1
 
- and 
 
b
 
-adrenergic receptors (a1/b) was
significantly higher on day 18; there was a non-significant, but slight decrease between days
18 and 20. There was an increase on day 22 (Table 3, Figure 4).
Regression analysis revealed very close correlations between PW/PER and E/P (Figure 5 a),
and between PW/PER and a1/b (Figure 5 b) (r2 5 0.910 and 0.949, respectively) on the differ-
ent days. A weaker correlation was found between E/P and a1/b (r2 5 0.797) (Figure 5 c).
Discussion
Research on pregnant uterine contractility is essential for an understanding of the pro-
cesses that occur during delivery, and for the possibility of influencing these processes. We
sought an animal model suitable for investigations of the ontogeny of contraction (the matu-
ration process of the pregnant myometrium, expressed as the changes in the ability to con-
tract toward term), in which changes are detectable during short periods of time and where
there is an estrogen dominance similarly to that in humans at the end of pregnancy. Accord-
ingly, we conducted experiments on pregnant rat: this offers a good model, with a 22-day pe-
riod of pregnancy and a relatively high plasma estrogen level at term [13].
Table 1
The pulse widths and period times for in vitro electric field stimulation eliciting maximum rhythmic contractions 
in late-pregnant rat uterine rings (n58)
Days of pregnancy
EFS parameters 15 18 20 22
PW (ms) 60.00 610.00 75.00 6 11.18 62.50 6 12.50 150.00 6 28.87
PER (s) 23.00 6 1.22 18.33 6 1.67 17.50 6 1.44 23.75 6 3.75
EFS5electric field stimulation, PW5pulse width [ms 6 S.E.M.], PER5period time [s 6 S.E.M.]
Fig. 2. Changes in contractility ratio (PW/PER) during late pregnancy in the rat (ns5not significant, *5p,0.05,
**5p,0.01, ***5p,0.001).
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EFS is an accepted method for in vitro investigations of the uterus. The two important pa-
rameters of EFS are PW and PER. PW determines the stimulation of the smooth muscle
through the nerve elements (,5 ms) or directly (.50 ms) [14]. In our investigations, direct
uterine stimulation was applied, with regard to the fact that a nerve element denervation pro-
cess can be detected at the end of pregnancy in rats [15]. Following the supramaximal stimu-
lation rule [16], 40 V was used as stimulus voltage.
The physiological contractions of the pregnant uterus are usually rhytmic, and we there-
fore tried to elicit such contractions. They were considered rhythmic if the isolated uterine
ring described a full contraction curve within one PER without a significant change in base-
line tone. The shorter the PER that can be applied, the better the tissue contractility. PW has
an important role in producing rhythmic contractions. With regard to the denervation process
in the late-pregnant uterus, the applied PW was 550 ms. Such a stimulus opens the voltage-
dependent Ca21 channels and starts an influx of Ca21 ions from the extracellular space to the
intracellular space, but does not alter the Na1 channels of the nerves. The background of this
selectivity is that the smooth muscle has a much longer time constant (60–133 ms) as com-
pared those with of the nerves (0.7–5.0 ms). The short stimuli therefore open the Na1 chan-
Table 2
The plasma 17b-estradiol [pM 6 S.E.M.] and progesterone [nM 6 S.E.M.] levels on different days of pregnancy 
in the rat (n57)
Days of pregnancy
Sex hormones 15 18 20 22
17b-estradiol (pM) 251.13 6 23.42 420.05 6 32.82 244.20 6 85.48 495.00 6 54.73
progesterone (nM) 269.54 6 38.52 168.18 6 12.62 148.10 6 18.44 26.10 6 13.14
Fig. 3. Changes in the ratio 17b-estradiol/progesterone (E/P) during late pregnancy in the rat (ns5not significant,
***5p,0.001).
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nels in the nerves, while stimuli greater than 50 ms selectively open the Ca21 channels of the
smooth muscle [7]. The smooth muscle has no significant intracellular Ca21 store. Although
sarcoplasmatic reticulum and ryanodine receptors are known in the myometrium, their roles
in smooth muscle contractile activation remain poorly understood [17,18]. The best known
uterine contracting agents, e.g. oxytocin and prostaglandins, lose their effects after removal
of the extracellular Ca21 [19]. The smooth muscle contraction therefore depends greatly on
the amount of extracellular Ca21 ions entering the cell. Accordingly, a longer PW allows a
higher concentration of Ca21 ions in the uterine smooth muscle cell, which can result (within
a given limit of approximately 50–200 ms) in stronger contractions. The longer the optimum
PW, therefore, the more difficult it is to describe a full contraction curve within one PER.
Thus, the longer the PW, the better the contractility. The elicited rhythmic contractions are
referred to as maximum because the stimulation parameters were chosen in such a way that
the tissues were not able to describe rhythmic contractions, or the AUCs were not higher for
shorter PER or longer PW values.
AUC evaluation is an accepted method of comparing contraction curves. We determined
the optimum stimulation parameters for maximum contractions via the AUCs. However, we
Table 3
Maximum numbers of binding sites (Bmax 6 S.E.M) of the adrenergic receptors on different days of pregnancy in 
the rat (n57)
Days of pregnancy
Receptor types 15 18 20 22
a1-adrenoceptor (fmol/mg protein) 344.93 6 10.16 420.05 6 32.82 244.20 6 85.48 495.00 6 54.73
b-adrenoceptor (fmol/mg protein) 15.99 6 0.81 9.57 6 1.62 7.21 6 1.11 9.68 6 0.82
Fig. 4. Changes in the ratio of a1- and b-receptor densities (a1/b) during late pregnancy in the rat (ns5not signif-
icant, *5p,0.05).
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Fig. 5. Correlations between the contractility ratio (PW/PER) and the ratio 17b-estradiol/progesterone (E/P) (a),
between PW/PER and the ratio a1/b-adrenoceptor (a1/b) (b), and between E/P and a1/b (c) in the late-pregnant
rat.
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could not deduce the ability of uterine tissue rings to undergo contraction from the AUC
values because there were no significant differences between the AUCs on the different days
of pregnancy. The contractility differences were therefore expressed by the stimulation pa-
rameters. Since a longer PW and a shorter PER mean a better ability to contract, we formed
the contractility ratio: the quotient of PW and PER. The higher PW/PER, the better the con-
tractility. By means of this number, the ontogeny of uterine contractility in late pregnancy in
the rat can be expressed numerically in vitro.
It is well known that sex hormones play an important role in the control of pregnant uter-
ine contractility. A relative predominance of progesterone decreases the contractility, while a
relative estrogen predominance increases it [20,21]. In a search for a physiological correla-
tion, regression analysis was carried out between E/P and PW/PER. A very close correlation
was found, which means that the in vitro contraction capability characterized by PW/PER is
in keeping with the physiological regularity.
One of the possible reasons for the elevation in PW/PER is the increased number of gap
junctions, which are thought to be deeply involved in the maturation process of the pregnant
myometrium. Their role in the uterine contractility is to form low voltage-dependent cell-to-
cell communications, heightening the electrical coupling between the smooth muscle cells,
which coordinates the contractions of labour [22]. Moreover, the connexins, the genes coding
gap junctions are very sensitive to changes in sexual hormone levels; some of them are very
sensitive to shifts in E/P ratio [23], which is confirmation of the increased contractility ratio
in parallel with E/P.
Another possible explanation of the elevated contractility ratio is the change in number of
the voltage-dependent Ca1 channels during pregnancy. The mRNA levels for these channels
are increased before term and preterm labour and prevented by progesterone treatment [24].
It is also known that E/P regulates the number of binding sites of adrenergic receptors in
the pregnant myometrium [25]. It was earlier demonstrated that a high density of a1-recep-
tors caused an increased spontaneous uterine motility in the postpartum rat myometrium in
vivo [26]. Our study revealed that the density of the a1-receptor is constantly 25–50 times
higher than the b-receptor density, and the changes in a1/b are mainly consequences of the
changes in a1-receptor concentration. Moreover, the very close correlation between PW/PER
and a1/b furnishes further evidence of the increased contractility caused by the high density
of a1-adrenergic receptors in the pregnant rat uterus. The weaker correlation between E/P and
a1/b is in keeping with the physiological fact that a high E/P mostly increases the sensitivity
of the a1-receptors, in spite of the great change in their numbers, especially at the end of
pregnancy [27,28]. This means that the increase in a1/b-receptor density does not occur
strictly in parallel with the increase in E/P, in contrast with the situation for PW/PER.
The decreases in the ability to contract and in the value of E/P or a1/b on day 20 can be re-
garded as a plateau phase in the maturation process of the pregnant myometrium. At this
stage of our research we have no clear explanation as to the physiological background of this
phenomenon, clarification of which requires further investigations. However, our results do
not contradict, but rather slightly modify the current picture of the ontogeny in the contractil-
ity of the pregnant rat uterus.
The evidence of our results leads us to suggest that EFS studies and PW/PER may allow
an in vitro characterization of the ability of the pregnant rat uterus to contract. We further pre-
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sume that this model can be suitable for the testing of the pharmacological effects of drugs
influencing the uterine contractility.
The in vivo contraction curves of the rat myometrium near labour are rhythmic, without
significant changes in their baseline tone [26]. Optimization of PW and leads to maximum
contractions in vitro which are most closely similar to the physiological contractions ob-
served during labour. Such regular maximum contractions can not be elicited by oxytocin or
prostaglandins in vitro. In vitro pharmacological studies may therefore furnish more reliable
information on such a model. It is suggested that pathophysiological conditions, eg. diabetes
[29] or hypertension [30], and pharmacotherapy [31] may change the contractility response
of the pregnant uterus. Our model may offer an experimental possibility to detect these
changes by the relatively simple determination of the contractility ratio.
As far as we aware, this is the first in vitro model which provides a numerical measure of
the ontogeny of the contractility of the uterus in late pregnancy. Our current data may also
suggest the significance of the a1-adrenergic receptors in pregnant uterine contractility,
which might open new perspectives in pharmacological control.
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